Trends in age- and sex-specific lung cancer mortality in Europe and Northern America: Analysis of vital registration data from the WHO Mortality Database between 2000 and 2017

被引:15
作者
Baum, Philip [1 ]
Winter, Hauke [1 ,2 ]
Eichhorn, Martin E. [1 ,2 ]
Roesch, Romina M. [1 ]
Taber, Samantha [3 ]
Christopoulos, Petros [2 ,4 ]
Wiegering, Armin [5 ]
Lenzi, Jacopo [6 ]
机构
[1] Heidelberg Univ Hosp, Dept Thorac Surg, Thoraxklin, Roentgenstr 1, D-69126 Heidelberg, Germany
[2] German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Neuenheimer Feld 156, D-69120 Heidelberg, Germany
[3] HELIOS Klinikum Emil Behring, Dept Thorac Surg, Heckeshorn Lung Clin, Walterhoferstr 11, D-14165 Berlin, Germany
[4] Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, Roentgenstr 1, D-69126 Heidelberg, Germany
[5] Univ Hosp Wuerzburg, Dept Gen Visceral Transplant Vasc & Pediat Surg, Oberduerrbacher Str 6, D-97080 Wurzburg, Germany
[6] Univ Bologna, Dept Biomed & Neuromotor Sci, Via San Giacomo 12, I-40126 Bologna, Italy
关键词
NSCLC; SCLC; Incidence; Smoking; Lung cancer; Mortality; CARBOPLATIN; PREDICTIONS; REGRESSION; GUIDELINE; GEFITINIB; NIVOLUMAB; SELECTION; SURVIVAL; OUTCOMES; SURGERY;
D O I
10.1016/j.ejca.2022.05.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the context of new targeted therapies and immunotherapy as well as screening modalities for lung cancer patients, detailed mortality trends in Europe and Northern America are unknown.Methods: Time-trend analysis using vital registration data of Northern America and Europe from the WHO Mortality Database (years 2000/2017). To assess improvements in lung cancer mortality, we performed a population-averaged Poisson autoregressive analysis. The average annual percent change (AAPC) was used as a summary measure of overall and country -specific trends in mortality. Second, we studied time trends of lung cancer incidence and smok-ing prevalence rates.Findings: In the total population of 872.5 million people between 2015 and 2017, the average annual age-standardised mortality from lung cancer was 54.6 deaths per 100 000, with sub-stantial differences across countries. Lung cancer was reported as the primary cause of death in 5.4 cases per 100 deaths. The age-standardised mortality rate decreased constantly (AAPC -1.5%) between 2000 and 2017. While mortality in men dropped annually by an average of -2.3%, mortality in women decreased by an average of-0.3%. This slight decline was driven exclusively by the USA. In contrast, 21 out of 31 countries registered a significant increase in female lung cancer mortality between 2000 and 2017, with Spain (AAPC 4.1%) and France (AAPC 3.6%) leading the list. Interpretation: Despite overall decreases in lung cancer mortality trends, female mortality re-mained unchanged or increased significantly in all countries except the USA. National mortal-ity outcomes reflect variabilities in tobacco control, screening, therapeutic advances, and access to health care. 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:269 / 279
页数:11
相关论文
共 57 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] [Anonymous], WHO Mortality Database
  • [3] Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
    Arnaoutakis, Konstantinos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) : 683 - 683
  • [4] Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
    Arnold, Melina
    Rutherford, Mark J.
    Bardot, Aude
    Ferlay, Jacques
    Andersson, Therese M-L
    Myklebust, Tor Age
    Tervonen, Hanna
    Thursfield, Vicky
    Ransom, David
    Shack, Lorraine
    Woods, Ryan R.
    Turner, Donna
    Leonfellner, Suzanne
    Ryan, Susan
    Saint-Jacques, Nathalie
    De, Prithwish
    McClure, Carol
    Ramanakumar, Agnihotram V.
    Stuart-Panko, Heather
    Engholm, Gerda
    Walsh, Paul M.
    Jackson, Christopher
    Vernon, Sally
    Morgan, Eileen
    Gavin, Anna
    Morrison, David S.
    Huws, Dyfed W.
    Porter, Geoff
    Butler, John
    Bryant, Heather
    Currow, David C.
    Hiom, Sara
    Parkin, D. Max
    Sasieni, Peter
    Lambert, Paul C.
    Moller, Bjorn
    Soerjomataram, Isabelle
    Bray, Freddie
    [J]. LANCET ONCOLOGY, 2019, 20 (11) : 1493 - 1505
  • [5] Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data
    Baum, Philip
    Lenzi, Jacopo
    Diers, Johannes
    Rust, Christoph
    Eichhorn, Martin E.
    Taber, Samantha
    Germer, Christoph-Thomas
    Winter, Hauke
    Wiegering, Armin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (10) : 1041 - +
  • [6] Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany
    Baum, Philip
    Diers, Johannes
    Haag, Johannes
    Klotz, Laura
    Eichhorn, Florian
    Eichhorn, Martin
    Wiegering, Armin
    Winter, Hauke
    [J]. LUNG CANCER, 2020, 149 : 78 - 83
  • [7] Cancer mortality in Europe in 2015 and an overview of trends since 1990
    Bertuccio, P.
    Alicandro, G.
    Malvezzi, M.
    Carioli, G.
    Boffetta, P.
    Levi, F.
    La Vecchia, C.
    Negri, E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (08) : 1356 - 1369
  • [8] Lung Cancer in Hungary
    Bogos, Krisztina
    Kiss, Zoltan
    Galffy, Gabriella
    Tamasi, Lilla
    Ostoros, Gyula
    Muller, Veronika
    Urban, Laszlo
    Bittner, Nora
    Sarosi, Veronika
    Vastag, Aladar
    Polanyi, Zoltan
    Nagy-Erdei, Zsofia
    Voko, Zoltan
    Nagy, Balazs
    Horvath, Krisztian
    Rokszin, Gyorgy
    Abonyi-Toth, Zsolt
    Barcza, Zsofia
    Moldvay, Judit
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 692 - 699
  • [9] Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
    Bogos, Krisztina
    Kiss, Zoltan
    Galffy, Gabriella
    Tamasi, Lilla
    Ostoros, Gyula
    Muller, Veronika
    Urban, Laszlo
    Bittner, Nora
    Sarosi, Veronika
    Vastag, Aladar
    Polanyi, Zoltan
    Nagy-Erdei, Zsofia
    Vok, Zoltan
    Nagy, Balazs
    Krisztian, Horvath
    Rokszin, Gyorgy
    Abonyi-Toth, Zsolt
    Moldvay, Judit
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639